First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial
Babiker, Abdel, Castro nee Green, Hannah, Compagnucci, Alexandra, Fiscus, Susan, Giaquinto, Carlo, Gibb, Diana M, Harper, Lynda, Harrison, Linda, Hughes, Michael, McKinney, Ross, Melvin, Ann, Mofenson, Lynne, Saidi, Yacine, Smith, M Elizabeth, Tudor-Williams, Gareth, Walker, A Sarah
Published in The Lancet infectious diseases (01.04.2011)
Published in The Lancet infectious diseases (01.04.2011)
Get full text
Journal Article
Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months
Jacqz-Aigrain, Evelyne, Harrison, Linda, Zhao, Wei, Compagnucci, Alexandra, Castro (née Green), Hannah, Farrelly, Laura, Saidi, Yacine, Hamadache, Djamel, Welch, Steven, Wintergerst, Uwe, Forcat, Silvia, Hadjou, Ghenima, Firtion, Ghislaine, Snowden, Wendy, Giaquinto, Carlo, Gibb, Diana, Burger, David
Published in Antiviral therapy (01.01.2010)
Published in Antiviral therapy (01.01.2010)
Get full text
Journal Article